Amiflamine
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292002This classification denotes a monoamine oxidase inhibitor with the molecular formula C12H20N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NE25WV9C8S, chemically known as benzeneethanamine, 4-(dimethylamino)-alpha,2-dimethyl-, (s) but generally known as amiflamine, which bears US NIH Compound Identifier 71221. European Medicines Agency schedules Amiflamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05428MIG. The term AMIFLAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). AMIFLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amiflamine under HS 29215990 and SITC 51455. As of Q4 2014, AMIFLAMINE remains the US FDA Preferred Term for this commodity. Amiflamine bears US NLM identifiers UMLS ID C0102947 and NCI Concept Code C72695. SMILES: N(c1cc(c(CC(N)C)cc1)C)(C)C.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.